0
     

Report Added
Report already added
Veterinary Diagnostics Market by Product (Instruments, Consumables), Technology (Immunodiagnostics (ELISA), Molecular Diagnostics (PCR, Microarrays), Hematology), Animal (Dogs, Cats, Cattle, Pigs), End User (Hospitals & Clinics) - Global Forecast to 2027

Veterinary Diagnostics Market by Product (Instruments, Consumables), Technology (Immunodiagnostics (ELISA), Molecular Diagnostics (PCR, Microarrays), Hematology), Animal (Dogs, Cats, Cattle, Pigs), End User (Hospitals & Clinics) - Global Forecast to 2027

The veterinary diagnostics market is expected to grow at a CAGR of 9.2% in the forecast period.

Veterinary diagnostics refers to the diagnosis of animal diseases and disorders using various veterinary diagnostic test kits, tools, and instruments such as clinical chemistry analyzers, hematology analyzers, glucose monitoring systems, urine analyzers, blood gas-electrolyte analyzers, and ELISA test kits.

The global veterinary diagnostics market is projected to reach USD 4.4 billion by 2027 from USD 2.8 billion in 2022, at a CAGR of 9.2%. Market growth can largely be attributed to the rising demand for animal-derived food products, the rising demand for pet insurance, growing animal health expenditure, and growth in the number of veterinary practitioners and income levels in developed economies. On the other hand, the lack of animal healthcare awareness and the shortage of veterinarians in emerging markets pose a challenge for the leading players operating in the market.

The consumables segment accounted for the larger share of the global veterinary diagnostics market

Based on products, the veterinary diagnostics market is segmented into consumables and instruments. In 2021, the consumables segment accounted for the larger share of the global veterinary diagnostics market. Consumables include blood glucose strips, urine glucose strips, urine test strips, ELISA rapid test kits, lateral flow rapid test kits, PCR tests, preloaded reagent clips and cartridges or panels, and other test reagents and consumables. The large share of the consumables segment can be attributed to the rising prevalence of zoonotic diseases and the growing animal population.

The clinical biochemistry segment accounted for the largest share of the global veterinary diagnostics market

Based on technology, the veterinary diagnostics market is segmented into clinical biochemistry, immunodiagnostics, molecular diagnostics, hematology, urinalysis, and other veterinary diagnostic technologies (includes microbiology and histopathology tests). In 2021, the clinical biochemistry segment accounted for the largest share of the global veterinary diagnostics market. Clinical biochemistry analyzers are more commonly adopted in veterinary diagnostic laboratories, leading to a higher share in the veterinary diagnostics market.

The companion animals segment is expected to register the highest growth during the forecast period

Based on animal type, the veterinary diagnostics market is segmented into companion animals and livestock. The companion animals segment is expected to register the highest growth of during the forecast period. This can be attributed to the growth in the companion animals market is mainly driven by the growing pet adoption due to rising urbanization, the growing expenditure on pet care, the increasing demand for pet insurance, the growing adoption of animal-assisted therapy, economic growth, and the rising incidence of age-related diseases in companion animals.

The Asia Pacific region is expected to register the highest CAGR in 2021

Geographically, the veterinary diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is expected to register the highest CAGR during the forecast period. Growth in pet adoption, increasing awareness about animal health, and growing per capita animal health expenditure, especially in India and China, are contributing to the growth of the APAC veterinary diagnostics market.

Breakdown of Primaries supply side:
In-depth interviews were conducted with various key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information, as well as to assess future market prospects. The distribution of primary interviews is as follows:

By Company Type: Tier 1- 60%, Tier 2- 30%, and Tier 3- 10%
By Designation: C-Level- 30%, Director Level- 50%, and Others- 20%
By Region: North America – 45%, Asia Pacific- 25%, Middle East & Africa – 5%, Europe- 15%, and Latin America – 10%

Key players in the veterinary diagnostics market
The prominent players in the veterinary diagnostics market are IDEXX Laboratories, Inc. (US), Zoetis, Inc. (US), Heska Corporation (US), Thermo Fisher Scientific Inc. (US), NEOGEN Corporation (US), Bio-Rad Laboratories Inc. (US), bioMérieux SA (France), Virbac (France), FUJIFILM Holdings Corporation (Japan), Shenzhen Mindray Animal Medical Technology Co. Ltd. (China), INDICAL BIOSCIENCE GmbH (Germany), BioNote, Inc. (South Korea), Biogal Galed Labs (Israel), Agrolabo S.p.A. (Italy), IDvet (France), Randox Laboratories Ltd. (Ireland), BioChek (Netherlands), Fassisi GmbH (Germany), Alvedia (France), SKYER, Inc. (South Korea), Shenzhen Bioeasy Biotechnology Co., Ltd. (China), Biopanda Reagents (UK), Precision Biosensor Inc. (South Korea), Skyla Corporation (China), and EUROIMMUN Medizinische Labordiagnostika AG (Germany).

Research Coverage:
The report analyzes the veterinary diagnostics market and aims at estimating the market size and future growth potential of this market based on various segments such as product, technology, animal type, end user and region. The report also includes a product portfolio matrix of various veterinary diagnostics products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
•Market Penetration: Comprehensive information on product portfolios offered by the top players in the global veterinary diagnostics market. The report analyzes this market by product, technology, animal type, end user, and region.
•Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global veterinary diagnostics market.
•Market Development: Comprehensive information on the lucrative emerging markets by product, technology, animal type, end user, and region.
•Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global veterinary diagnostics market.
•Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global veterinary diagnostics market.
Table of Contents

1INTRODUCTION54
1.1STUDY OBJECTIVES54
1.2MARKET DEFINITION54
1.2.1INCLUSIONS AND EXCLUSIONS55
1.3MARKET SCOPE56
1.3.1MARKETS COVERED56
1.3.2YEARS CONSIDERED57
1.4CURRENCY CONSIDERED57
TABLE 1EXCHANGE RATES UTILIZED FOR CONVERSION TO USD57
1.5LIMITATIONS57
1.6STAKEHOLDERS58
1.7SUMMARY OF CHANGES58
2RESEARCH METHODOLOGY59
2.1RESEARCH DATA59
FIGURE 1RESEARCH DESIGN59
2.1.1SECONDARY DATA59
2.1.1.1Key data from secondary sources61
2.1.2PRIMARY DATA61
FIGURE 2PRIMARY SOURCES61
2.1.2.1Key data from primary sources62
2.1.2.2Insights from Primary Experts63
FIGURE 3BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS63
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS, BY COMPANY TYPE, DESIGNATION, AND REGION64
FIGURE 5BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS, BY END USER, DESIGNATION, AND REGION64
2.2MARKET SIZE ESTIMATION65
FIGURE 6SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS65
FIGURE 7REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC.66
FIGURE 8SUPPLY-SIDE ANALYSIS OF TOP COMPANIES: VETERINARY DIAGNOSTICS MARKET (2021)67
FIGURE 9CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF VETERINARY DIAGNOSTICS MARKET (2022–2027)68
FIGURE 10CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS68
FIGURE 11TOP-DOWN APPROACH69
2.3MARKET BREAKDOWN & DATA TRIANGULATION70
FIGURE 12MARKET DATA TRIANGULATION METHODOLOGY70
2.4MARKET SHARE ANALYSIS71
2.5ASSUMPTIONS71
2.6RISK ASSESSMENT72
TABLE 2RISK ASSESSMENT: VETERINARY DIAGNOSTICS MARKET72
3EXECUTIVE SUMMARY73
FIGURE 13VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)73
FIGURE 14VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION)74
FIGURE 15VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022 VS. 2027 (USD MILLION)75
FIGURE 16VETERINARY DIAGNOSTICS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)75
FIGURE 17GEOGRAPHICAL SNAPSHOT OF VETERINARY DIAGNOSTICS MARKET76
4PREMIUM INSIGHTS77
4.1VETERINARY DIAGNOSTICS MARKET OVERVIEW77
FIGURE 18GROWING PREVALENCE OF ZOONOTIC DISEASES TO DRIVE MARKET GROWTH77
4.2ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY END USER AND COUNTRY (2021)78
FIGURE 19VETERINARY REFERENCE LABORATORIES ACCOUNTED FOR LARGEST SHARE OF APAC MARKET IN 202178
4.3VETERINARY DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES79
FIGURE 20CHINA TO REGISTER HIGHEST GROWTH IN VETERINARY DIAGNOSTICS MARKET DURING FORECAST PERIOD79
4.4VETERINARY DIAGNOSTICS MARKET: DEVELOPED VS. DEVELOPING MARKETS80
FIGURE 21DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD80
5MARKET OVERVIEW81
5.1INTRODUCTION81
5.2MARKET DYNAMICS81
FIGURE 22VETERINARY DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES81
5.2.1MARKET DRIVERS82
5.2.1.1Growth in companion animal population82
TABLE 3PET POPULATION, BY ANIMAL, 2014–2020 (MILLION)83
5.2.1.2Rising demand for animal-derived food products83
TABLE 4PAST AND PROJECTED TRENDS IN CONSUMPTION OF MEAT AND MILK IN DEVELOPED AND DEVELOPING COUNTRIES84
TABLE 5ASIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)84
TABLE 6ASIA: COUNTRY-LEVEL PRODUCTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)85
5.2.1.3Increasing incidence of transboundary and zoonotic diseases85
TABLE 7ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009–2019)85
5.2.1.4Rising demand for pet insurance and growing animal health expenditure86
TABLE 8US: AVERAGE PREMIUMS PAID (2019–2021)87
FIGURE 23CANADA: AVERAGE ANNUAL PREMIUMS, 2017–202187
FIGURE 24US: PET INDUSTRY EXPENDITURE, 2010–202188
TABLE 9US: BREAKDOWN OF PET INDUSTRY EXPENDITURE, 2020 VS. 2021 (USD BILLION)88
TABLE 10NORTH AMERICA: PET HEALTH INSURANCE MARKET, 2012–2021 (USD MILLION)89
5.2.1.5Growing number of veterinary practitioners and rising income levels in developed economies89
TABLE 11NUMBER OF VETERINARIANS AND PARAVETERINARIANS IN DEVELOPED COUNTRIES, 2012–201890
5.2.1.6Increasing disease control and disease prevention measures90
TABLE 12MARKET DRIVERS: IMPACT ANALYSIS91
5.2.2MARKET RESTRAINTS91
5.2.2.1Rising pet care costs91
FIGURE 25US: BASIC ANNUAL EXPENSES FOR DOGS AND CATS, 202192
5.2.2.2High costs of veterinary diagnostic tests92
TABLE 13MARKET RESTRAINTS: IMPACT ANALYSIS93
5.2.3MARKET OPPORTUNITIES93
5.2.3.1Increased use of PCR testing panels to rule out COVID-19 virus in animals93
5.2.3.2Untapped emerging markets93
TABLE 14MARKET OPPORTUNITIES: IMPACT ANALYSIS94
5.2.4MARKET CHALLENGES94
5.2.4.1Lack of animal healthcare awareness in emerging countries94
5.2.4.2Shortage of veterinary practitioners in developing markets94
TABLE 15NUMBER OF VETERINARY PROFESSIONALS, BY COUNTRY, 2005 VS. 2014 VS. 201895
TABLE 16MARKET CHALLENGES: IMPACT ANALYSIS95
5.3INDUSTRY TRENDS96
5.3.1ADOPTION OF MULTIPLE TESTING PANELS96
TABLE 17MULTIPLE TESTING PANELS VS. SINGLE TESTING PANELS96
5.3.2OUTSOURCING OF VETERINARY DIAGNOSTIC TESTING SERVICES96
5.3.3GROWING CONSOLIDATION IN VETERINARY DIAGNOSTICS INDUSTRY96
TABLE 18MAJOR ACQUISITIONS IN ANIMAL HEALTH DIAGNOSTICS INDUSTRY97
5.3.4GROWING SCALE OF VETERINARY BUSINESSES97
5.4DISEASE TRENDS98
5.4.1LIVESTOCK98
5.4.1.1Avian Influenza (AI)98
5.4.1.2African Swine Fever (ASF)98
5.4.1.3Bovine Babesiosis (BB)98
5.4.1.4Peste des Petits Ruminants (PPR)98
5.4.1.5West Nile Virus (WNV)98
5.4.2COMPANION ANIMALS99
5.4.2.1Zoonotic diseases99
TABLE 19COMMON ZOONOTIC DISEASES SPREAD BY COMPANION ANIMALS99
5.4.2.2Obesity & diabetes100
5.5TECHNOLOGICAL ANALYSIS100
5.5.1KEY TECHNOLOGIES100
5.5.1.1Development of portable instruments for POC diagnostic services100
TABLE 20PONT-OF-CARE PORTABLE VETERINARY DIAGNOSTIC INSTRUMENTS101
5.5.2ADJACENT TECHNOLOGIES101
5.5.2.1Development of rapid and sensitive veterinary diagnostic kits101
5.6PRICING ANALYSIS101
TABLE 21REGIONAL PRICING ANALYSIS OF VETERINARY ANALYZERS, 2021 (USD)102
5.6.1AVERAGE SELLING PRICES OF KEY PLAYERS, BY APPLICATION102
TABLE 22AVERAGE SELLING PRICES OF KEY PLAYERS FOR TOP 3 APPLICATIONS (USD)102
5.7VALUE CHAIN ANALYSIS103
FIGURE 26VETERINARY DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS103
5.8ECOSYSTEM MARKET MAP103
FIGURE 27VETERINARY DIAGNOSTICS MARKET: ECOSYSTEM PARTICIPANTS104
FIGURE 28VETERINARY DIAGNOSTICS MARKET: ECOSYSTEM MARKET MAP104
5.9PORTER’S FIVE FORCES ANALYSIS105
TABLE 23VETERINARY DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS105
5.9.1THREAT FROM NEW ENTRANTS105
5.9.2THREAT FROM SUBSTITUTES106
5.9.3BARGAINING POWER OF SUPPLIERS106
5.9.4BARGAINING POWER OF BUYERS106
5.9.5INTENSITY OF COMPETITIVE RIVALRY106
5.10SUPPLY CHAIN ANALYSIS107
FIGURE 29VETERINARY DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS108
5.11REGULATORY ANALYSIS108
5.11.1US108
5.11.2EUROPE109
5.12PATENT ANALYSIS109
5.12.1PATENT PUBLICATION TRENDS FOR VETERINARY DIAGNOSTICS109
FIGURE 30PATENT PUBLICATION TRENDS (JANUARY 2011–AUGUST 2022)110
5.12.2INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS110
FIGURE 31TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR VETERINARY DIAGNOSTIC PATENTS (JANUARY 2011–JULY 2022)111
FIGURE 32TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY DIAGNOSTIC PATENTS (JANUARY 2011–JULY 2022)112
5.13KEY CONFERENCES & EVENTS DURING 2022–2023112
TABLE 24VETERINARY DIAGNOSTICS MARKET: DETAILED LIST OF CONFERENCES & EVENTS112
5.14REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS113
5.14.1NORTH AMERICA113
TABLE 25NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS113
5.14.2EUROPE115
TABLE 26EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS115
5.14.3REST OF THE WORLD116
TABLE 27REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS116
5.15KEY STAKEHOLDERS & BUYING CRITERIA116
5.15.1KEY STAKEHOLDERS IN BUYING PROCESS116
FIGURE 33INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 APPLICATIONS116
TABLE 28INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 APPLICATIONS117
5.15.2BUYING CRITERIA117
FIGURE 34KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS117
TABLE 29KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS117
6VETERINARY DIAGNOSTICS MARKET, BY PRODUCT118
6.1INTRODUCTION119
TABLE 30VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)119
6.2CONSUMABLES119
6.2.1CONSUMABLES ACCOUNTED FOR LARGEST SHARE OF VETERINARY DIAGNOSTIC PRODUCTS MARKET119
TABLE 31KEY VETERINARY DIAGNOSTIC CONSUMABLES AVAILABLE IN MARKET (2021)120
TABLE 32VETERINARY DIAGNOSTIC CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)121
6.3INSTRUMENTS121
6.3.1INCREASING POINT-OF-CARE APPLICATIONS FOR EARLY DIAGNOSIS AND PRECISION IN LIVESTOCK FARMING TO DRIVE MARKET GROWTH121
TABLE 33KEY VETERINARY DIAGNOSTIC INSTRUMENTS AVAILABLE IN MARKET (2021)122
TABLE 34VETERINARY DIAGNOSTIC INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)123
7VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY124
7.1INTRODUCTION125
TABLE 35VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)125
TABLE 36VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)126
7.2CLINICAL BIOCHEMISTRY126
TABLE 37KEY VETERINARY CLINICAL BIOCHEMISTRY PRODUCTS AVAILABLE IN MARKET127
TABLE 38VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)127
TABLE 39VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)128
7.2.1CLINICAL CHEMISTRY ANALYSIS128
TABLE 40CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)129
TABLE 41CLINICAL CHEMISTRY ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)129
7.2.1.1Clinical chemistry reagent clips & cartridges130
7.2.1.1.1Rising number of screening tests performed to drive market growth130
TABLE 42CLINICAL CHEMISTRY REAGENT CLIPS & CARTRIDGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)130
7.2.1.2Clinical chemistry analyzers131
7.2.1.2.1Increasing installation of clinical chemistry analyzers to propel growth131
TABLE 43CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)131
7.2.2GLUCOSE MONITORING132
TABLE 44GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)132
TABLE 45GLUCOSE MONITORING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)133
7.2.2.1Blood glucose strips133
7.2.2.1.1Growing demand for blood glucose strips in home care settings to drive growth133
TABLE 46BLOOD GLUCOSE STRIPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)134
7.2.2.2Glucose monitors134
7.2.2.2.1Growing incidence of diabetes in pet animals to drive adoption of glucose monitors134
TABLE 47GLUCOSE MONITORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)135
7.2.2.3Urine glucose strips135
7.2.2.3.1Growing risk of DKA in animals to drive market growth135
TABLE 48URINE GLUCOSE STRIPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)136
7.2.3BLOOD GAS & ELECTROLYTE ANALYSIS136
TABLE 49BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)137
TABLE 50BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)137
7.2.3.1Blood gas & electrolyte reagent clips and cartridges138
7.2.3.1.1Easy availability of animal species-specific preloaded reagent clips to support market138
TABLE 51BLOOD GAS & ELECTROLYTE REAGENT CLIPS AND CARTRIDGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)138
7.2.3.2Blood gas & electrolyte analyzers139
7.2.3.2.1Growing use of blood gas & electrolyte analyzers to determine oxygen and carbon dioxide levels in blood to drive growth139
TABLE 52BLOOD GAS & ELECTROLYTE ANALYZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)139
7.3IMMUNODIAGNOSTICS140
TABLE 53KEY VETERINARY IMMUNODIAGNOSTIC PRODUCTS AVAILABLE IN MARKET140
TABLE 54VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)141
TABLE 55VETERINARY IMMUNODIAGNOSTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)142
7.3.1LATERAL FLOW ASSAYS142
TABLE 56LATERAL FLOW ASSAYS MARKET, BY TYPE, 2020–2027 (USD MILLION)143
TABLE 57LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)143
7.3.1.1Lateral flow rapid tests144
7.3.1.1.1Lateral flow rapid tests to dominate market during forecast period144
TABLE 58LATERAL FLOW RAPID TESTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)144
7.3.1.2Lateral flow strip readers145
7.3.1.2.1Growing need of lateral flow strip readers to determine quantity of analytes in samples to drive adoption145
TABLE 59LATERAL FLOW STRIP READERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)145
7.3.2ELISA TESTS146
7.3.2.1Advantages such as cost-effectiveness and ease of use to drive demand for ELISA tests146
TABLE 60ELISA TESTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)146
7.3.3ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS147
7.3.3.1Increasing incidence of allergies in companion animals to drive market growth147
TABLE 61ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)147
7.3.4IMMUNOASSAY ANALYZERS148
7.3.4.1Growing use of immunoassay analyzers for livestock to propel market148
TABLE 62IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)148
7.3.5OTHER IMMUNODIAGNOSTIC PRODUCTS149
TABLE 63OTHER IMMUNODIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)149
7.4MOLECULAR DIAGNOSTICS150
TABLE 64VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)150
TABLE 65VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)151
7.4.1PCR TESTS151
7.4.1.1Increased laboratory usage of PCR in proteomics and genomics to support growth151
TABLE 66PCR TESTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)152
7.4.2MICROARRAYS152
7.4.2.1Growing applications of biochips for infectious disease identification to propel market152
TABLE 67MICROARRAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)153
7.4.3OTHER MOLECULAR DIAGNOSTIC PRODUCTS153
TABLE 68OTHER MOLECULAR DIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)154
7.5HEMATOLOGY154
TABLE 69KEY VETERINARY HEMATOLOGY PRODUCTS AVAILABLE IN MARKET155
TABLE 70VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)155
TABLE 71VETERINARY HEMATOLOGY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)156
7.5.1HEMATOLOGY CARTRIDGES156
7.5.1.1Extensive use of hematology cartridges along with hematology analyzers for complete blood analysis to fuel growth156
TABLE 72HEMATOLOGY CARTRIDGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)157
7.5.2HEMATOLOGY ANALYZERS157
7.5.2.1High usage of hematology analyzers by veterinary hospitals & clinics to support growth157
TABLE 73HEMATOLOGY ANALYZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)158
7.6URINALYSIS158
TABLE 74KEY VETERINARY URINALYSIS PRODUCTS AVAILABLE IN MARKET159
TABLE 75VETERINARY URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)159
TABLE 76VETERINARY URINALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)160
7.6.1URINALYSIS CLIPS & CARTRIDGES/PANELS160
7.6.1.1Growing use of clips and cartridges in urine analyzers to detect single or multiple electrolytes to drive market160
TABLE 77URINALYSIS CLIPS & CARTRIDGES/PANELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)161
7.6.2URINE ANALYZERS161
7.6.2.1Development of easy-to-use urine analyzers for POC testing to drive market growth161
TABLE 78URINE ANALYZERS MARKET, BY COUNTRY, 2020–2027 USD MILLION)162
7.6.3URINE TEST STRIPS162
7.6.3.1Rising occurrence of kidney diseases in cats and dogs to support market162
TABLE 79URINE TEST STRIPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)163
7.7OTHER VETERINARY DIAGNOSTIC TECHNOLOGIES163
TABLE 80OTHER VETERINARY DIAGNOSTIC TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)164
8VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE165
8.1INTRODUCTION166
TABLE 81VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)166
8.2COMPANION ANIMALS166
TABLE 82VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION)167
TABLE 83VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2020–2027 (USD MILLION)167
8.2.1DOGS168
8.2.1.1Largest number of pets insured were dogs in 2020—a key factor driving market growth168
TABLE 84DOG POPULATION, BY COUNTRY, 2012–2020 (MILLION)169
TABLE 85VETERINARY DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY, 2020–2027 (USD MILLION)169
8.2.2CATS170
8.2.2.1Growing pet cat population to support growth170
TABLE 86CAT POPULATION, BY COUNTRY, 2012–2020 (MILLION)170
TABLE 87ANNUAL COSTS ASSOCIATED WITH CAT-BORNE DISEASES IN AUSTRALIA, 2020 (MILLION)171
TABLE 88VETERINARY DIAGNOSTICS MARKET FOR CATS, BY COUNTRY, 2020–2027 (USD MILLION)171
8.2.3HORSES172
8.2.3.1Growing equine health awareness to drive growth172
TABLE 89EQUINE POPULATION, BY COUNTRY, 2012–2019 (THOUSAND)172
FIGURE 35NUMBER OF PRIVATE EQUINE CLINICAL PRACTICES IN US, 2009–2020173
TABLE 90VETERINARY DIAGNOSTICS MARKET FOR HORSES, BY COUNTRY, 2020–2027 (USD MILLION)173
8.2.4OTHER COMPANION ANIMALS174
TABLE 91VETERINARY DIAGNOSTICS MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2020–2027 (USD MILLION)174
8.3LIVESTOCK175
TABLE 92VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2020–2027 (USD MILLION)176
TABLE 93VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY COUNTRY, 2020–2027 (USD MILLION)176
8.3.1CATTLE177
8.3.1.1Growing consumption of meat to support market growth177
FIGURE 36MEAT PRODUCTION, BY TYPE, 2019–2020 (THOUSAND TONNES)177
TABLE 94CATTLE POPULATION, BY COUNTRY, 2012–2019 (MILLION)178
FIGURE 37MILK PRODUCTION, BY REGION, 2016–2020 (THOUSAND TONNES)178
TABLE 95VETERINARY DIAGNOSTICS MARKET FOR CATTLE, BY COUNTRY, 2020–2027 (USD MILLION)179
8.3.2PIGS179
8.3.2.1Growing incidence of infectious diseases to drive market growth179
TABLE 96SWINE POPULATION, BY COUNTRY, 2012–2019 (MILLION)180
FIGURE 38ANNUAL PER CAPITA MEAT CONSUMPTION PROJECTIONS, DEVELOPING VS. DEVELOPED COUNTRIES, 2020–2030180
TABLE 97VETERINARY DIAGNOSTICS MARKET FOR PIGS, BY COUNTRY, 2020–2027 (USD MILLION)181
8.3.3POULTRY181
8.3.3.1Increasing demand for poultry meat to contribute to market growth181
TABLE 98POULTRY POPULATION, BY COUNTRY, 2012–2019 (MILLION)182
TABLE 99VETERINARY DIAGNOSTICS MARKET FOR POULTRY, BY COUNTRY, 2020–2027 (USD MILLION)183
8.3.4OTHER LIVESTOCK ANIMALS183
TABLE 100VETERINARY DIAGNOSTICS MARKET FOR OTHER LIVESTOCK ANIMALS, BY COUNTRY, 2020–2027 (USD MILLION)184
9VETERINARY DIAGNOSTICS MARKET, BY END USER185
9.1INTRODUCTION186
TABLE 101VETERINARY DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)186
9.2VETERINARY REFERENCE LABORATORIES187
9.2.1LARGE VOLUME OF SAMPLES RECEIVED BY VETERINARY REFERENCE LABORATORIES TO DRIVE MARKET GROWTH187
TABLE 102VETERINARY DIAGNOSTICS MARKET FOR VETERINARY REFERENCE LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)187
9.3VETERINARY HOSPITALS & CLINICS188
9.3.1GROWING PET OWNERSHIP AND SPENDING ON PET CARE TO PROPEL MARKET188
FIGURE 39US: GROWING NUMBER OF VETERINARIANS IN PRIVATE CLINICAL PRACTICES (2012–2020)188
TABLE 103VETERINARY DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2020–2027 (USD MILLION)189
9.4POINT-OF-CARE/IN-HOUSE TESTING189
9.4.1EASE OF USE, COST-EFFECTIVENESS, AND SWIFT RESULTS OFFERED BY POINT-OF-CARE TESTS TO DRIVE DEMAND189
TABLE 104VETERINARY DIAGNOSTICS MARKET FOR POINT-OF-CARE/IN-HOUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION)190
9.5VETERINARY RESEARCH INSTITUTES & UNIVERSITIES190
9.5.1INCREASING COLLABORATIONS BETWEEN PRIVATE COMPANIES AND VETERINARY RESEARCH INSTITUTES TO SUPPORT GROWTH190
TABLE 105VETERINARY DIAGNOSTICS MARKET FOR VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2020–2027 (USD MILLION)191
10VETERINARY DIAGNOSTICS MARKET, BY REGION192
10.1INTRODUCTION193
TABLE 106VETERINARY DIAGNOSTICS MARKET, BY REGION, 2020–2027 (USD MILLION)193
10.2NORTH AMERICA193
FIGURE 40EXPECTED GROWTH IN NUMBER OF VETERINARIANS IN NORTH AMERICA194
FIGURE 41NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET SNAPSHOT195
TABLE 107NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)195
TABLE 108NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)196
TABLE 109NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)196
TABLE 110NORTH AMERICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)197
TABLE 111NORTH AMERICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)197
TABLE 112NORTH AMERICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)197
TABLE 113NORTH AMERICA: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)198
TABLE 114NORTH AMERICA: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)198
TABLE 115NORTH AMERICA: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)198
TABLE 116NORTH AMERICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)199
TABLE 117NORTH AMERICA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)199
TABLE 118NORTH AMERICA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)199
TABLE 119NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)200
TABLE 120NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION)200
TABLE 121NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2020–2027 (USD MILLION)200
TABLE 122NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)201
10.2.1US201
10.2.1.1US to dominate North American veterinary diagnostics market during forecast period201
FIGURE 42US: POPULATION OF DOGS, 2012–2020 (MILLION)202
FIGURE 43US: EXPENDITURE ON VET VISITS202
TABLE 123HEALTHCARE EXPENDITURE ON COMPANION ANIMALS, 2018 VS. 2020202
FIGURE 44INCOME OF VETERINARIANS IN US, 2017–2021203
FIGURE 45NUMBER OF VETERINARIANS IN US, 2016–2020203
TABLE 124US: FOOD-PRODUCING ANIMAL POPULATION, 2001–2019 (MILLION)204
TABLE 125US: NUMBER OF VETERINARIANS IN PRIVATE CLINICAL PRACTICES, 2014–2020204
TABLE 126US: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)205
TABLE 127US: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)205
TABLE 128US: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)206
TABLE 129US: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)206
TABLE 130US: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)206
TABLE 131US: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)207
TABLE 132US: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)207
TABLE 133US: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)207
TABLE 134US: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)208
TABLE 135US: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)208
TABLE 136US: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)208
TABLE 137US: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)209
TABLE 138US: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION)209
TABLE 139US: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2020–2027 (USD MILLION)209
TABLE 140US: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)210
10.2.2CANADA210
10.2.2.1Growing pet adoption in Canada to drive market growth210
FIGURE 46CANADA: COMPANION ANIMAL POPULATION, 2016–2020 (MILLION)211
TABLE 141CANADA: LARGE ANIMAL POPULATION, 2001–2019 (MILLION)211
TABLE 142CANADA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)211
TABLE 143CANADA: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)212
TABLE 144CANADA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)212
TABLE 145CANADA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)213
TABLE 146CANADA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)213
TABLE 147CANADA: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)213
TABLE 148CANADA: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)214
TABLE 149CANADA: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)214
TABLE 150CANADA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)214
TABLE 151CANADA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)215
TABLE 152CANADA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)215
TABLE 153CANADA: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)215
TABLE 154CANADA: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION)216
TABLE 155CANADA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2020–2027 (USD MILLION)216
TABLE 156CANADA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)217
10.3EUROPE217
TABLE 157EUROPE: COMPANION POPULATION, 2019 (MILLION)218
TABLE 158EUROPE: LIVESTOCK POPULATION, 2019 (MILLION)218
FIGURE 47EU27: LIVESTOCK POPULATION, 2012–2019 (MILLION)219
TABLE 159EUROPE: NUMBER OF VETERINARIANS, 2012–2019219
TABLE 160EUROPE: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)220
TABLE 161EUROPE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)220
TABLE 162EUROPE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)221
TABLE 163EUROPE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)221
TABLE 164EUROPE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)222
TABLE 165EUROPE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)222
TABLE 166EUROPE: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)222
TABLE 167EUROPE: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)223
TABLE 168EUROPE: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)223
TABLE 169EUROPE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)223
TABLE 170EUROPE: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)224
TABLE 171EUROPE: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)224
TABLE 172EUROPE: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)224
TABLE 173EUROPE: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION)225
TABLE 174EUROPE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2020–2027 (USD MILLION)225
TABLE 175EUROPE: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)226
10.3.1GERMANY226
10.3.1.1Rising awareness of zoonotic diseases to drive market growth226
TABLE 176GERMANY: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION)227
TABLE 177GERMANY: COMPANION ANIMAL POPULATION, 2016–2019 (MILLION)227
TABLE 178GERMANY: NUMBER OF VETERINARIANS, 2014 VS. 2019227
TABLE 179GERMANY: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)228
TABLE 180GERMANY: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)228
TABLE 181GERMANY: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)229
TABLE 182GERMANY: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)229
TABLE 183GERMANY: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)230
TABLE 184GERMANY: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)230
TABLE 185GERMANY: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)230
TABLE 186GERMANY: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)231
TABLE 187GERMANY: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)231
TABLE 188GERMANY: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)231
TABLE 189GERMANY: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)232
TABLE 190GERMANY: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)232
TABLE 191GERMANY: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION)232
TABLE 192GERMANY: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2020–2027 (USD MILLION)233
TABLE 193GERMANY: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)233
10.3.2UK233
10.3.2.1Increasing pet ownership to make UK relatively large market for veterinary diagnostics233
TABLE 194UK: PET POPULATION, 2017–2020 (MILLION)234
TABLE 195UK: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION)234
TABLE 196UK: NUMBER OF VETERINARIANS, 2014 VS. 2019235
TABLE 197UK: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)235
TABLE 198UK: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)235
TABLE 199UK: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)236
TABLE 200UK: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)236
TABLE 201UK: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)236
TABLE 202UK: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)237
TABLE 203UK: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)237
TABLE 204UK: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)237
TABLE 205UK: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)238
TABLE 206UK: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)238
TABLE 207UK: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)238
TABLE 208UK: VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)239
TABLE 209UK: VETERINARY DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION)239
TABLE 210UK: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2020–2027 (USD MILLION)239
TABLE 211UK: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)240
10.3.3FRANCE240
10.3.3.1Willingness of pet owners to spend on health of companion pets to contribute to growth240
TABLE 212FRANCE: PET POPULATION, 2017–2020 (MILLION)240
TABLE 213FRANCE: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION)241
TABLE 214FRANCE: NUMBER OF VETERINARIANS, 2014 VS. 2017241
TABLE 215FRANCE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)241
TABLE 216FRANCE: VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)242
TABLE 217FRANCE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)242
TABLE 218FRA

Report Title: Veterinary Diagnostics Market by Product (Instruments, Consumables), Technology (Immunodiagnostics (ELISA), Molecular Diagnostics (PCR, Microarrays), Hematology), Animal (Dogs, Cats, Cattle, Pigs), End User (Hospitals & Clinics) - Global Forecast to 2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

2023 What's Next for Vietnam Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Vietnam Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Venezuela Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Venezuela Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for US Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for US Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Uruguay Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Uruguay Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for United Arab Emirates Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for United Arab Emirates Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Ukraine Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Ukraine Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM